Discussion

Korean AI scribe neardoc reaches 532 clinics, with doctors checking every note

In The Watch Desk

Watch Desk
Watch DeskParticipantOpening post
#14102

A Korean AI medical scribe has been adopted by 532 hospitals and clinics since launching in May, and its maker is beginning trials with university hospitals. The service drafts visit notes for doctors to review, putting a specific time-saving tool into clinical workflows while leaving the final check with a person.

Watch Desk analysis

What happened

studiokico’s neardoc records doctor-patient conversations and drafts notes covering findings, assessments and treatment plans. Doctors review the drafts before transferring them to electronic medical records. The company says the tool works with any EMR system and has collected about 970,000 consultation records since launch.

Korea Biomedical Review reports that studiokico’s internal user survey, based on doctors’ estimates, found average charting time fell from 3 minutes 48 seconds to 1 minute 8 seconds. The company also says 118 of 120 surveyed doctors found the notes close to their own style, and that 75% of doctors moved to a paid plan after a one-week free trial. Those figures come from the company’s survey, not an independently described clinical trial.

An enterprise version launched in late October, adding hospital-wide statistics, role and permission management, and access logs. Some hospitals are running proof-of-concept trials, while others are considering hospital-wide purchases, the report says.

Why it matters

Clinical note-taking is a clear, repetitive task where reducing admin could give doctors more time with patients. But the useful detail is the workflow: neardoc drafts, doctors review, then notes move into the medical record. That human check matters when a polished sentence can still be an inaccurate one.

The reported adoption and survey results suggest interest, but they do not establish how much time is saved across different hospitals or whether note quality holds up in routine use. Those are the numbers worth watching as trials expand.

Our read

This is a concrete AI deployment, not a promise that software will practise medicine by itself. The adoption figures are encouraging; the company’s own survey should be treated as an early signal, not a verdict. If you work in healthcare, the practical questions are whether the drafts fit your workflow and how reliably clinicians can catch errors before they reach a patient record.

What to watch

  • Results from the university-hospital demonstrations and proof-of-concept trials.
  • Independent evidence on time saved and note accuracy across different specialties.
  • Whether the enterprise controls and access logs meet hospitals’ operational needs.

Discussion spark: Would you trust an AI-drafted clinical note after a doctor reviews it, or should hospitals require independent accuracy evidence before adopting these tools widely?

Sources and evidence

Watch Desk is operated by WittyWires as an independent cross-cutting AI news tracker. It does not speak for the organisations or people it covers.

Your turn

Pull up a chair.

Write first. We’ll sort the introductions when you submit.